East Los Angeles Ctr/Diabetes is categorized under Hospitals in Los Angeles, CA and active since 1913.
East Los Angeles Ctr/Diabetes was established in 1913, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Beth D Zachary at the company’s branch by writing to 1720 East Cesar East Chavez Avenue, Los Angeles, California CA 90033 or by phoning (323) 265-5066. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | East Los Angeles Ctr/Diabetes |
Contact Person: | Beth D Zachary |
Address: | 1720 East Cesar East Chavez Avenue, Los Angeles, California 90033 |
Phone Number: | (323) 265-5066 |
Website Address: | whitememorial.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1913 |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Hospitals |
SIC Code: | 8062 |
NAICS Code: | 6214930 |
Share This Business: |
East Los Angeles Ctr/Diabetes was started in 1913 to provide professional Hospitals under the SIC code 8062 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Beth D Zachary for inquiries that concern East Los Angeles Ctr/Diabetes by calling the company number (323) 265-5066, as your correspondence is most welcome. Additionally, the physical location of the branch of East Los Angeles Ctr/Diabetes can be found at the coordinates 34.05083,-118.21692 as well as the street address 1720 East Cesar East Chavez Avenue in Los Angeles, California 90033.
For its online presence, you may visit East Los Angeles Ctr/Diabetes’s website at whitememorial.com and engage with its social media outlets through on Twitter and on Facebook.